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1. Introduction 
Natural products have long served as important targets for 
total synthesis, attracting attention with their intiguing biological 
activities and impressive molecular architectures.1  Synthetic 
efforts toward natural products frequently inspire diversification 
studies due to ready availability of complex late-stage 
intermediates.2,3  Generally embodying the main carbon 
frameworks of the associated natural product families, these 
scaffolds serve as ideal platforms for diversification.  They 
enable access to complex derivatives unattainable through 
operational biosynthetic pathways2 and can be more accessible 
than the natural products themselves (for instance, du  to low-
yielding endgame transformations toward the latter).4,5 
Furthermore, diversification of a natural product saffold can 
generate an array of complex molecules while also revealing 
important reactivity patterns of the molecular framework.3,6     
Related natural product families often feature similar carbon 
skeletons while exhibiting varied biological activities.6a 
Derivitization of the common framework produces “hybrid” 
molecules incorporating salient features (e.g. oxidation states, 
substitution patterns, functional groups) of the parent families 
that could exhibit heightened potency or even novel activity.4,7  
This strategy was employed to good effect by the Patrson group 
in their preparation of discodermolide–dictyostatin hybrids which 
displayed greater potency than the parent compounds against 
pancreatic, colon, and ovarian cancer cell lines.8  Inspired by 
these efforts, we sought to create hybrid compounds resembling 
another pair of bioactive marine natural product families, the 
cyanthiwigins and the gagunins.   
Comprising a subset of a large class of bioactive natural 
products known as the cyathins, the cyanthiwigin diterpenoids 
were first isolated from the marine sponge Epipolasis reiswigi n 
1992,9 with more compounds extracted from Myrmekioderma 
styx a decade later.10  With the exception of cyanthiwigin AC, the 
cyanthiwigins possess 5–6–7 fused tricyclic carbon skeletons (1) 
featuring four contiguous stereocenters, two of which are 
quaternary.  Additionally, many of these compounds display 
noteworthy biological activity against such disease agents as 
HIV-1 (cyanthiwigin B, 2), lung cancer and leukemia cells 
(cyanthiwigin C, 3), and primary tumor cells (cyanthiwigin F, 4)
(Figure 1). 
 
Figure 1. The cyathane skeleton and selected cyanthiwigins. 
Since not all of the cyanthiwigins have been isolated in large 
enough quantities for biological evaluation, exhaustive 
exploration of the medicinal properties of all thiry known 
cyanthiwigins has remained elusive.  Noting this limitation along 
with the structural challenges presented by the molecules, 
chemists have targeted various members of the cyanthiwigin 
family for total synthesis.11,12  To date, ten cyanthiwigins have 
been prepared, including cyanthiwigins U, W, and Z by Phillips 
and co-workers;13 cyanthiwigin AC by Reddy and co-workers;14 
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cyanthiwigins B, F, and G by Stoltz and co-workers;15 and 
cyanthiwigins A, C, G, and H by Gao and co-workers.16   
Featuring the same 5–6–7 tricyclic core as the cyanthiwigins, 
the structurally related gagunin diterpenoids were isolated from 
the sponge Phorbas sp. by Shin and co-workers off the coast of 
South Korea and exhibit varying biological activities.17  An 
important structural difference between the gagunins a d the 
cyanthiwigins is the degree of oxidation surrounding the 
carbocyclic core.  The density of functionalization a d presence 
of numerous contiguous stereocenters (up to 11) render the 
gagunins challenging targets for total synthesis, and s such, only 
partial syntheses of the gagunins have been completed to date.18     
The gagunins exhibit cytotoxic activity against the uman 
leukemia cell line K562, with gagunin E (5) displaying the most 
potent activity (LC50 = 0.03 µg/mL) out of all 17 known members 
of the natural product family.  Gagunin E (5) is over one 
thousand times more potent than the least biologically active 
member of the family, gagunin A (6) (Figure 2).  Interestingly, 
these two compounds differ only in the placement and identity of 
the ester substituents surrounding the carbocyclic framework, an 
observation that led Shin and co-workers to hypothesize that the 
biological properties of the gagunins are highly sensitive to the 
ester functionalities, especially at the C11 positin.  Indeed, 
evaluation of perhydroxylated gagunin A (7), in which all of the 
esters are hydrolyzed, revealed no appreciable biological activity, 
lending credence to Shin’s hypothesis.  
Figure 2. Structures and anti-leukemia activities of selected 
gagunins. 
With this in mind, we envisioned that tricycle 8 could serve as 
a platform for accessing non-natural compounds resembling both 
the cyanthiwigin and gagunin natural products.  Available in 7 
steps from succinic acid via a double enantioselectiv  
decarboxylative allylic alkylation strategy,15,19 compound (–)-8 
had previously been employed in a comparative study of late-
stage C–H functionalization (Scheme 1).20  Along with allylic C–
H oxidation of 8, various methods for 2° C–H chlorination and 3° 
C–H hydroxylation, amination, and azidation of hydrogenated 
tricycle 10 were compared.  These efforts revealed reactivity 
patterns of the cyanthiwigin core and identified robust protocols 
for C–H oxidation of complex molecules.   
For the present study, we anticipated that the two carbonyls 
and C-ring olefin in 8 could serve as functional handles for facile 
installation of ester functionalities, generating poly-esterified 
compounds (13–14) reminiscent of the densely oxygenated 
gagunins (Scheme 2).  Given the diverse biological ativities 
displayed by the parent cyanthiwigins and gagunins, we
hypothesized that some of these cyanthiwigin–gagunin “hybrid” 
molecules might exhibit interesting biological properties that 
could be correlated to structure through systematic fine-tuning of 
the ester substituents.  Overall, these efforts could identify 
exceptionally potent complex molecules7 while providing insight 
into the reactivity of the cyanthiwigin core and the relationship 
between framework substitution and biological activity. 
Scheme 1. Previous work using the cyanthiwigin scaffold (8) in a 
comparative study of late-stage C–H oxidation. 
 
Scheme 2. Approach toward cyanthiwigin–gagunin hybrid 
synthesis. 
2. Results and Discussion 
At the outset, we identified the C-ring olefin in 8 as a key 
starting point for diversification.  Oxygenation could be achieved 
through di-hydroxylation of the olefin with either anti or syn 
relative stereochemistry, giving rise to cyanthiwigin–gagunin 
hybrids diastereomeric at C12 and C13.  Retrosynthetically, 
hybrids 13 and 14 could arise through reduction and bis-
esterification of diketones 15 or 16, respectively.  These 
intermediates would be accessed through either anti- or syn-
dihydroxylation of 8, followed by esterification (Scheme 3). 
 
Scheme 3. Retrosynthetic analysis of hybrids 13–14. 
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2.1. Anti diol route 
We began our studies targeting hybrid molecules (13) derived 
from the anti-dihydroxylation pathway.  We envisioned that the 
anti-diol moiety could be installed in the C-ring by way of olefin 
epoxidation and subsequent ring-opening.  To this end, we 
treated tricycle 8 with DMDO at 0 °C, forming epoxide 17 in 
excellent yield as a single diastereomer (Scheme 4).  As observed 
in our previous studies on the hydrogenation and C–H 
functionalization of the cyanthiwigin core,20 oxygenation 
occurred selectively from the α-face of the molecule, likely due 
to steric shielding of the β-face by the methyl substituent at the 
B–C ring juncture.  After unsuccessful attempts to open the 
epoxide under basic conditions (e.g., NaOH, LiEt3BH), we found 
that treatment of epoxide 17 with catalytic perchloric acid 
delievered the desired anti-diol (18) in excellent yield.   
 
Scheme 4. Preparation of 18 via acid-catalyzed opening of 17. 
Pleased with this result, we proceeded to repeat the sequence 
on a larger scale.  While epoxidation of 8 consistently occurred in 
excellent yield and facial selectivity, the acid-catalyzed epoxide-
opening of 17 proved less reliable.  When 50 mg of epoxide 17 
was subjected to conditions that had been effective on 5 mg, the 
formation of multiple products was observed (Scheme 5).  These 
compounds were isolated by column chromatography and
characterized as compounds 18–23.  The desired anti-diol (18) 
comprised the major product at 32% yield while diastereomeric 
anti-diol 19 constituted the next most abundant product.  
Meinwald rearrangement21 products 20 and 21 were formed in 
roughly equal amounts, and elimination products 22 and 23 were 
obtained in the smallest quantities. 
 
Scheme 5. Formation of compounds 18–23 from 17 (50 mg). 
As evidenced by the low selectivity of this transformation, 
further exploration is needed to identify a scalable and reliable 
procedure for the preparation of anti-diol 18.22  In the meantime, 
we progressed diol 18 to tricyclic ester 15 en route to 13 (Scheme 
6) and turned our attention toward synthesis of yn-diol-derived 
hybrids (14).   
 
Scheme 6. Synthesis of 15 en route to cyanthiwigin–gagunin 
hybrids 13. 
 
2.2. Syn-diol route 
Preparation of the syn-diol-derived hybrids commenced with 
dihydroxylation of 8 using osmium tetroxide and NMO (Scheme 
7).  We were pleased to find that syn-diol 24 was formed in good 
yield as a single diastereomer under these conditios. Diol 24 
was subsequently treated with butyric acid, EDCI, and DMAP to 
achieve selective esterification of the secondary C13 hydroxyl, 
furnishing tricyclic mono-ester 16 in moderate yield.  Treatment 
of 16 with excess sodium borohydride resulted in the formation 
of triol 25, a key intermediate in the syn-diol route. 
 
Scheme 7. Preparation of triol 25. 
Notably, hydride reduction occurred selectively from the α-
face of diketone 16, presumably due to steric factors as in 
previous cases.  We propose that the C9 and C6 methyls control 
facial selectivity of reduction by blocking hydride approach from 
the Burgi–Dunitz angle23 on the β-face. Thus, hydride attack 
occurs from the more accessible α-face despite the concavity of 
the three-dimensional architecture of 16.  This gives rise to the 
observed stereochemistry at C3 and C8 in the product (25) 
(Figure 3).  
 
 
 
Figure 3. Stereochemical rationalization for formation of 25.
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With tris-hydroxylated intermediate 25 in hand, we 
proceeded to the final transformation in generating cyanthiwigin–
gagunin hybrids 14.  Initial efforts at bis-esterification employing 
the same conditions used previously (butyric acid, EDCI, and 
DMAP) proved unsuccessful, returning large quantities of 
unreacted 25 (Table 1, Entry 1).  Further attempts to access tri-
ester 14a using butyryl chloride and DMAP were also 
ineffective, instead producing a complex mixture of products 
(Entry 2).  Finally, we discovered that the combination of butyric 
anhydride, triethylamine, and DMAP provided the optimal 
balance in reactivity, supplying cyanthiwigin–gagunin hybrid 
14a in high yield (Entry 3).  Gratifyingly, application of these 
conditions to 25 using isovaleric anhydride or acetic anhydride 
enabled access to hybrids 14b or 14c, respectively (Scheme 8). 
 
Table 1. Optimization of esterification conditions for 
synthesis of cyanthiwigin–gagunin hybrid 14a. 
 
Scheme 8. Synthesis of cyanthiwigin–gagunin hybrids 14a–c 
from common intermediate 25. 
Noting the varying efficacies of esterification conditions 
employed in the preparation of 14a, we re-examined the 
esterification of diol 24 (Table 2).  Although the desired ester 
(16) was generated in serviceable quantities in every case, use of 
butyric anhydride and triethylamine in the presence of DMAP 
(Entry 3) resulted in significantly higher yields, in agreement 
with our previous findings.   
 
Table 2. Comparison of conditions for esterification of 24. 
For the preparation of cyanthiwigin–gagunin hybrid 14a, we 
wondered if a global esterification strategy might be feasible 
through tetra-hydroxylated intermediate 26 (Scheme 9).  To 
investigate this possibility, we treated diol 24, this time prepared 
through a catalytic dipotassium osmate dihydrate protocol, with 
excess sodium borohydride.  Despite good conversion of 24, the 
expected tetra-hydroxylated product (26) proved intractable, 
likely due to its high polarity and resistance to extraction from 
the aqueous layer.  As such, we determined that a global 
esterification strategy through a tetra-hydroxylated intermediate 
was not a viable approach for the preparation of cyanthiwigin–
gagunin hybrids containing three identical ester substituents.  
 
Scheme 9. Investigation of a global esterification strategy 
toward hybrid 14a. 
 
2.3. Biological studies 
Biological evaluation of synthetic intermediates has been 
carried out in collaboration with investigators at the City of Hope 
Comprehensive Cancer Center.  Preliminary results indicate that 
compounds 14a, 14b, 14c, 19, 20, 21, 22, 23, and 25 do not 
exhibit significant potency against A2058 melanoma or DU145 
prostate cancer cell lines at 10µM after 48 hours, but there 
remain opportunities for further evaluation of these and other 
compounds against more disease agents. 
 
2.4. Future directions 
True to the nature of late-stage diversification research 
programs, there exist an abundance of further avenues for 
cyanthiwigin–gagunin hybrid synthesis and biological 
 5 
exploration.  For each synthetic route to a hybrid molecule (e.g. 
syn-diol route, anti-diol route, etc.), there are nearly infinite 
combinations of ester functionalities that can be appended to the 
tricyclic core.  Initial investigations have centered around 
butanoate, acetate, and isovalerate substituents based on their 
ubiquity among the natural gagunins, but as more insights into 
the activities of these compounds are gained, the ester 
functionalities can be re-designed to probe biological influence.   
 
3. Conclusion 
These investigations have revealed notable patterns of 
reactivity in the tricyclic framework of the cyanthiwigin and 
gagunin natural products.  Transformations involving the C-ring 
olefin and the A- and B-ring carbonyls in 8 have enabled us to 
conclude that the β-face of the molecule is substantially less 
accessible than the α-face, likely due to steric hindrance 
originating from the C9 and C6 methyl substituents.  We have 
prepared a variety of cyanthiwigin–gagunin hybrid molecules 
using a common late-stage intermediate (25) available in three 
steps from the cyanthiwigin natural product core (8).  These 
compounds arose through a syn-dihydroxylation pathway, and 
after further optimization this strategy can also be employed in 
the preparation of hybrids through an anti-dihydroxylation 
pathway.  Initial biological studies have not indicated appreciable 
cytotoxicity against melanoma and prostate cancer cell lines, but 
there remains much potential for further investigation.  
In conclusion, a vast number of compounds are accessibl  
through a multitude of synthetic pathways, including those yet to 
be examined.  We anticipate that the synthetic insight  derived 
from these exploratory studies will provide a strong foundation 
from which to launch further efforts toward the synthesis and 
biological evaluation of cyanthiwigin–gagunin hybrid molecules. 
   
4. Experimental Section 
4.1. General 
Unless noted in the specific procedure, reactions were 
performed in flame-dried glassware under argon atmosphere.  
Dried and deoxygenated solvents (Fisher Scientific) were 
prepared by passage through columns of activated aluminum 
before use.24  Methanol (Fisher Scientific) was distilled from 
magnesium methoxide immediately prior to use.  Commercial 
reagents (Sigma Aldrich or Alfa Aesar) were used as receiv d.  
Triethylamine (Oakwood Chemical) was distilled from calcium 
hydride immediately prior to use.  Dimethyldioxirane (DMDO) 
was prepared according to known procedure25 immediately prior 
to use.  Brine is defined as a saturated aqueous solution of 
sodium chloride.  Reactions requiring external heat were 
modulated to the specified temperatures using an IKAmag 
temperature controller.  Reaction progress was monitored by 
thin-layer chromatography (TLC) or Agilent 1290 UHPLC-
LCMS.  TLC was performed using E. Merck silica gel 60 F254 
precoated plates (0.25 mm) and visualized by UV fluorescence 
quenching, potassium permanganate, or p-anisaldehyde staining.  
SiliaFlash P60 Academic Silica gel (particle size 0.040–0.063 
mm) was used for flash chromatography.   
1H and 13C NMR spectra were recorded on a Varian Inova 500 
spectrometer (500 MHz and 126 MHz, respectively), a Bruker 
AV III HD spectrometer equipped with a Prodigy liquid nitrogen 
temperature cryoprobe (400 MHz and 101 MHz, respectivly), a 
Varian Mercury 300 spectrometer (300 MHz and 75 MHz, 
respectively), or a Varian Inova 600 (at 600 MHz for 1H NMR 
only) instrument, and are reported in terms of chemical shift 
relative to residual CHCl3 (δ 7.26 and δ 77.16 ppm, respectively).  
Data for 1H NMR spectra are reported as follows: chemical shift 
(δ ppm) (multiplicity, coupling constant (Hz), integration).  
Abbreviations are used as follows: s = singlet, bs = road singlet, 
d = doublet, t = triplet, q = quartet, m = complex multiplet.  
Infrared (IR) spectra were recorded on a Perkin Elmer Paragon 
1000 spectrometer using thin film samples on KBr plates and are 
reported in frequency of absorption (cm–1).  High-resolution mass 
spectra (HRMS) were obtained from the Caltech Mass Spectral 
Facility using a JEOL JMS-600H High Resolution Mass 
Spectrometer with fast atom bombardment (FAB+) ionization 
mode or were acquired using an Agilent 6200 Series TOF with 
an Agilent G1978A Multimode source in electrospray ionization 
(ESI+) mode.  Optical rotations were measured with a Jasco P-
1010 polarimeter at 589 nm using a 100-mm path-length cell.  
4.2. Preparative Procedures for anti-diol-derived hybrids 
4.2.1. Epoxide 17 .   
To a solution of tricyclic diketone 8 (50.0 mg, 0.192 mmol, 
1.0 equiv) in acetone (2.0 mL) at 0 °C was added a solution of 
DMDO (0.0125M in acetone, 16.9 mL, 0.211 mmol, 1.1 equiv).  
The resulting mixture was stirred at 0 °C for 90 minutes, after 
which time the volatiles were removed under reduced pressure, 
affording epoxide 17 as a pale yellow oil (52.0 mg, 99% yield).  
This material was used without further purification.  Rf = 0.36 
(50% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 
2.72 (t, J = 7.5, 14.4 Hz, 1H), 2.65 (d, J = 14.7 Hz, 1H), 2.52 
(dddd, J = 19.5, 10.3, 2.0, 0.9 Hz, 1H), 2.37 (dddd, J = 19.4, 
10.2, 9.1, 1.2 Hz, 1H), 2.30–2.22 (m, 1H), 2.12 (td, J = 7.3, 2.8 
Hz, 1H), 2.07 (d, J = 14.8 Hz, 1H), 2.05–1.94 (m, 2H), 1.90 (d, J 
= 12.2 Hz, 1H), 1.80–1.73 (m, 1H), 1.66 (ddd, J = 12.3, 11.1, 2.8 
Hz, 1H), 1.55–1.48 (m, 1H), 1.45–1.37 (m, 1H), 1.33 (s, 3H), 
1.30–1.24 (m, 1H), 1.11 (s, 3H), 0.88 (s, 3H); 13C NMR (CDCl3, 
126 MHz) δ 217.7, 211.9, 62.5, 60.3, 59.3, 52.2, 50.7, 47.4, 43.8, 
41.8, 34.4, 34.3, 31.3, 23.9, 22.2, 21.7, 17.0; IR (Neat Film, KBr) 
2958, 2932, 1736, 1705, 1466, 1383, 1171, 1007, 875, 73  cm–1; 
HRMS (ESI+) m/z calc’d for C17H25O3 [M+H]
+: 277.1798, found 
277.1789; [α]25D –68.4 (c 0.12, CHCl3).   
4.2.2. Ant i -d io l  18 .   
To a solution of epoxide 17 (5.0 mg, 0.0181 mmol, 1.0 equiv) 
in THF (1.0 mL) at 23 °C was added perchloric acid (3 wt % 
solution in H2O, 20 µL, 5.43 µmol, 0.3 equiv).  The resulting 
mixture was stirred at 23 °C for 72 hours, after which time the 
reaction was diluted with ethyl acetate (5 mL) and washed with 
sat. aq. NaHCO3 (5 mL), and brine (5 mL).  The combined 
organics were dried over MgSO4, filtered, and concentrated, and 
the crude residue was purified by silica gel column 
chromatography (30%  40%   50%   60%   75% ethyl acetate 
in hexanes) to afford anti-diol 18 as a colorless oil (4.8 mg, 90% 
yield).  Rf = 0.10 (25% hexanes in ethyl acetate); 
1H NMR 
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(CDCl3, 600 MHz) δ 3.88 (d, J = 10.1 Hz, 1H), 2.66 (d, J = 
15.0 Hz, 1H), 2.53–2.44 (m, 1H), 2.41–2.33 (m, 1H), 2.27–2.21 
(m, 1H), 2.16 (d, J = 15.0 Hz, 1H), 1.97–1.88 (m, 3H), 1.78–1.74 
(m, 1H), 1.70–1.66 (m, 1H), 1.65 (m, 1H), 1.51 (m, 1H), 1.43 (m, 
2H), 1.22 (s, 3H), 1.13 (s, 3H), 0.90 (s, 3H); 13C NMR (CDCl3, 
126 MHz) δ 217.9, 212.2, 75.9, 74.1, 61.4, 52.9, 51.0, 46.5, 46.0, 
41.8, 40.0, 34.3, 31.0, 24.5, 21.8, 19.9, 19.1; IR (Neat Film, KBr) 
3444 (br), 2959, 2933, 1735, 1702, 1464, 1385, 1176, 085, 992, 
735 cm-1; HRMS (EI+) m/z calc’d for C17H27O4 [M+H]
+: 
295.1909, found 295.1887; [α]25D –48.1 (c 1.62, CHCl3). 
4.2.3. Epoxide-opening s ide products 19–23 .   
To a solution of epoxide 17 (47.2 mg, 0.171 mmol, 1.0 equiv) 
in THF (8.5 mL) at 23 °C was added perchloric acid (3 wt % 
solution in H2O, 0.17 mL, 0.0512 mmol, 0.3 equiv).  The 
resulting mixture was stirred at 23 °C for 72 hours, after which 
time the reaction was diluted with ethyl acetate (10 mL) and 
washed with sat. aq. NaHCO3 (10 mL), and brine (10 mL).  The 
combined organics were dried over MgSO4, filtered, and 
concentrated, and the crude residue was purified by silica gel 
column chromatography (30%  50%   60%   75%   100% 
ethyl acetate in hexanes) to afford diol 18 (16.3 mg, 32% yield) 
along with side products 19–23.  Yields and chacaterization data 
for 19–23 are listed below.  
4.2.3.1. Diol  19 .   
7.2 mg, 14% yield.  Rf = 0.15 (25% hexanes in ethyl acetate); 
1H NMR (CDCl3, 400 MHz) δ 3.85 (d, J = 10.3 Hz, 1H), 2.86 (d, 
J = 15.8 Hz, 1H), 2.60 (d, J = 6.7 Hz, 1H), 2.40–2.33 (m, 2H), 
2.17 (d, J = 16.1 Hz, 1H), 2.08–2.04 (m, 1H), 1.96–1.91 (m, 2H), 
1.86–1.83 (m, 1H), 1.73 (m, 1H), 1.60–1.54 (m, 1H), 1.51–1.46 
(m, 2H), 1.29–1.27 (m, 1H), 1.20 (s, 3H), 1.19 (s, 3H), 1.08 (s, 
3H); 13C NMR (CDCl3, 101 MHz) δ 221.7, 214.9, 75.8, 73.8, 
60.1, 50.1, 49.0, 46.5, 44.9, 42.2, 39.8, 37.2, 32.4, 30.6, 24.8, 
24.0, 21.5; IR (Neat Film, KBr) 3451 (br), 2958, 2932, 1737, 
1704, 1455, 1384, 1268, 1169, 1147, 1087, 1070, 1036, 7 5 cm-1; 
HRMS (EI+) m/z calc’d for C17H27O4 [M+H]
+: 295.1909, found 
295.1938; [α]25D –6.3 (c 0.72, CHCl3). 
4.2.3.2. Aldehyde 20 .   
5.5 mg, 12% yield.  Rf = 0.65 (25% hexanes in ethyl acetate); 
1H NMR (CDCl3, 500 MHz) δ 9.49 (d, J = 1.5 Hz, 1H), 2.52–
2.46 (m, 2H), 2.42–2.36 (m, 1H), 2.35–2.30 (m, 1H), 2.29–2.23 
(m, 2H), 2.19 (d, J = 14.8 Hz, 1H), 1.97 (dd, J = 14.2, 2.4 Hz, 
1H), 1.88–1.83 (m, 2H), 1.81–1.75 (m, 1H), 1.54 (m, 1H), 1.23–
1.17 (m, 1H), 1.12 (s, 3H), 1.11–1.07 (m, 1H), 0.94 (s, 3H), 0.64 
(s, 3H); 13C NMR (CDCl3, 126 MHz) δ 217.2, 211.5, 205.0, 61.0, 
52.4, 51.3, 48.4, 45.9, 41.3, 39.0, 34.3, 31.8, 31.3, 25.0, 21.8, 
21.8, 18.4; IR (Neat Film, KBr) 2957, 2931, 1738, 1704 
(overlapping peaks), 1456, 1384, 1135, 839 cm-1; HRMS (EI+) 
m/z calc’d for C17H25O3 [M+H]
+: 277.1804, found 277.1819; 
[α]25D –41.5 (c 0.55, CHCl3).   
4.2.3.3. Tr iketone 21 .   
5.2 mg, 11% yield.  Rf = 0.50 (25% hexanes in ethyl acetate); 
1H NMR (CDCl3, 400 MHz) δ 2.80 (d, J = 11.7 Hz, 1H), 2.74 (d, 
J = 15.0 Hz, 1H), 2.53 (dddd, J = 19.4, 10.3, 2.0, 0.8 Hz, 1H), 
2.42 (m, 1H), 2.38–2.34 (m, 1H), 2.34–2.29 (m, 1H), 2.28–2.24 
(m, 1H), 2.16–2.10 (m, 2H), 2.01–1.89 (m, 2H), 1.82–1.75 (m, 
2H), 1.38–1.30 (m, 1H), 1.25–1.19 (m, 1H), 1.13 (s, 3H), 1.07 (d, 
J = 7.1 Hz, 3H), 0.76 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ 
217.6, 214.4, 211.4, 61.4, 54.2, 52.2, 50.9, 48.3, 46.5, 40.3, 34.3, 
32.6, 31.2, 25.7, 21.7, 19.0, 18.6; IR (Neat Film, KBr) 2960, 
2930, 1738, 1704 (overlapping peaks), 1456, 1384, 1222, 1176, 
1053 cm-1; HRMS (EI+) m/z calc’d for C17H25O3 [M+H]
+: 
277.1804, found 277.1814; [α]25D –5.4 (c 0.52, CHCl3).   
4.2.3.4. Al ly l ic  a lcohol  22 .   
4.3 mg, 9% yield.  Rf = 0.37 (25% hexanes in ethyl acetate); 
1H NMR (CDCl3, 400 MHz) δ 5.56–5.51 (m, 1H), 4.52 (d, J = 
9.5 Hz, 1H), 2.93 (d, J = 14.9 Hz, 1H), 2.56–2.48 (m, 1H), 2.43–
2.30 (m, 3H), 2.10 (d, J = 14.7 Hz, 1H), 1.97–1.90 (m, 2H), 1.87 
(m, 1H), 1.77 (s, 3H), 1.75–1.69 (m, 2H), 1.58–1.54 (m, 1H), 
1.11 (s, 3H), 0.92 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ 218.2, 
212.3, 143.1, 124.7, 69.6, 61.1, 52.9, 51.5, 49.1, 41.7, 41.6, 34.4, 
31.1, 24.3, 21.7, 20.7, 19.6; IR (Neat Film, KBr) 345  (br), 2960, 
2923, 1737, 1704, 1462, 1384, 1164, 1124, 1051, 1002, 890, 735 
cm-1; HRMS (EI+) m/z calc’d for C17H25O3 [M+H]
+: 277.1804, 
found 277.1796; [α]25D –46.1 (c 0.43, CHCl3). 
4.2.3.5. Al ly l ic  a lcohol  23 .   
3.4 mg, 7% yield.  Rf = 0.31 (25% hexanes in ethyl acetate); 
1H NMR (CDCl3, 400 MHz) δ 5.05 (s, 1H), 4.97 (s, 1H), 4.31 
(dd, J = 10.1, 5.5 Hz, 1H), 2.71 (d, J = 14.6 Hz, 1H), 2.60–2.49 
(m, 1H), 2.43–2.22 (m, 5H), 2.09 (d, J = 14.6 Hz, 1H), 1.89–1.81 
(m, 1H), 1.80–1.71 (m, 4H), 1.22 (m, 1H), 1.10 (s, 3H), 0.80 (s, 
3H); 13C NMR (CDCl3, 101 MHz) δ 217.8, 212.3, 153.6, 113.6, 
71.1, 62.6, 53.0, 50.9, 49.1, 45.1, 41.1, 34.4, 31.3 (x2), 28.9, 
21.7, 17.3; IR (Neat Film, KBr) 3437 (br), 2928, 2871, 1732, 
1704, 1455, 1384, 1262, 1165, 1019, 995, 905 cm-1; HRMS (EI+) 
m/z calc’d for C17H25O3 [M+H]
+: 277.1804, found 277.1803; 
[α]25D –47.6 (c 0.34, CHCl3). 
 
   
4.2.4. Monoester  15 .   
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To a solution of diol 18 (13.0 mg, 0.0442 mmol, 1.0 equiv) in 
dichloromethane (4.0 mL) was added triethylamine (25 µL, 0.177 
mmol, 4.0 equiv), butyric anhydride (22 µL, 0.132 mmol, 3.0 
equiv), and DMAP (2.7 mg, 0.0221 mmol, 0.5 equiv) at 23 °C.  
The resulting mixture was stirred for 30 minutes, after which 
time TLC analysis indicated full consumption of 18.  The 
reaction was diluted with dichloromethane (5 mL) and washed 
with water (2 x 10 mL).  The organic layer was dried over 
MgSO4, filtered, and concentrated under reduced pressure, and 
the resulting crude residue was purified by silica gel column 
chromatography (10%  30%   50% ethyl acetate in hexanes) to 
afford monoester 15 as a colorless oil (9.8 mg, 61% yield).  Rf = 
0.30 (50% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) 
δ 4.99 (d, J = 10.7 Hz, 1H), 2.55 (d, J = 15.0 Hz, 1H), 2.52–2.44 
(m, 1H), 2.41–2.34 (m, 1H), 2.33 (t, J = 7.4 Hz, 2H), 2.21 (m, 
1H), 2.13 (d, J = 15.1 Hz, 1H), 2.00–1.88 (m, 3H), 1.82–1.72 (m, 
2H), 1.67 (q, J = 7.5 Hz, 2H), 1.61 (m, 1H), 1.50–1.37 (m, 3H), 
1.14 (s, 3H), 1.14 (s, 3H), 0.96 (t, J = 7.4 Hz, 3H), 0.94 (s, 3H); 
13C NMR (CDCl3, 126 MHz) δ 217.7, 211.8, 174.4, 78.5, 75.1, 
60.9, 52.7, 51.0, 47.2, 44.4, 41.6, 40.1, 36.6, 34.3, 31.1, 25.5, 
21.8, 19.6, 18.6, 18.5, 13.8; IR (Neat Film, KBr) 3459 (br), 2963, 
2933, 1732, 1705, 1463, 1456, 1380, 1260, 1177, 1086, 9 5 cm-1; 
HRMS (ESI+) m/z calc’d for C21H31O4 [M–OH]
+: 347.2217, 
found 347.2218; [α]25D –44.4 (c 0.26, CHCl3). 
 
4.3. Preparative Procedures for syn-diol-derived hybrids  
4 .3.1. Tr icyc l ic  Dio l  24 .   
To a solution of tricyclic diketone 8 (10 mg, 0.0384 mmol, 1.0 
equiv) in 1:1 THF/H2O (3.5 mL total volume) at 0 °C were added 
NMO (4 wt % solution in H2O, 50 µL, 8.5 µmol, 0.22 equiv) and 
osmium tetroxide (50 wt % solution in H2O, 0.1 mL, 0.410 
mmol, 10.7 equiv).  The resulting mixture was stirred at 0 °C for 
4 hours, after which time TLC analysis showed full consumption 
of 8.  The reaction was quenched at 0 °C with saturated aq. 
Na2S2O3 and stirred vigorously for 4 hours before being diluted 
with dichloromethane (15 mL).  The layers were separated, and 
the aqueous layer was extracted with dichloromethane (2 x 10 
mL).  The combined organic layers were washed with brine (20 
mL) and dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The crude residue was purified by silica gel 
column chromatography (30%   50%   70%   90% ethyl acetate 
in hexanes) to afford tricyclic diol 24 as a colorless oil (6.7 mg, 
60% yield).  Rf = 0.10 (25% hexanes in ethyl acetate); 
1H NMR 
(CDCl3, 500 MHz) δ 3.62 (d, J = 10.1 Hz, 1H), 2.73 (d, J = 15.2 
Hz, 1H), 2.50 (dd, J = 19.6, 10.2 Hz, 1H), 2.35 (dd, J = 19.6, 9.5 
Hz, 1H), 2.29–2.23 (m, 1H), 2.14 (d, J = 16.2 Hz, 1H), 2.05–1.98 
(m, 2H), 1.95 (d, J = 14.5 Hz, 1H), 1.86 (m, 1H), 1.79 (d, J = 
11.3 Hz, 1H), 1.76–1.72 (m, 1H), 1.52 (t, J = 25.0, 13.0 Hz, 1H), 
1.32 (d, J = 14.6 Hz, 1H), 1.28 (s, 3H), 1.12 (s, 3H), 1.06–0.98 
(m, 1H), 0.82 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 218.2, 
212.4, 74.2, 72.9, 61.2, 53.1, 51.0, 46.6, 45.5, 40.9, 40.1, 34.3, 
31.0, 27.9, 21.8, 20.2, 19.3; IR (Neat Film, KBr) 3448 (br), 
2961, 2934, 1735, 1702, 1466, 1384, 1176, 1125, 916, 731 cm-1; 
HRMS (FAB+) m/z calc’d for C17H25O3 [M–OH]
+: 277.1804, 
found 277.1804; [α]25D –225.2 (c 1.00, CHCl3). 
4.3.2. Dihydroxy lat ion of  8  us ing d ipotassium 
osmate d ihydrate.   
To a solution of tricyclic diketone 8 (50 mg, 0.192 mmol, 1.0 
equiv) in 4:1 acetone/H2O (10 mL total volume) at 0 °C were 
added NMO (45.0 mg, 0.384 mmol, 2.0 equiv) and dipotassium 
osmate dihydrate (7.1 mg, 0.0192 mmol, 0.1 equiv).  The 
resulting mixture was stirred at 0 °C for 7 hours, after which time 
TLC analysis showed full consumption of 8.  The reaction was 
quenched with saturated aq. Na2S2O3 at 0 °C and stirred 
vigorously for 30 minutes before being diluted with 
dichloromethane (15 mL).  The layers were separated, an  the 
aqueous layer was extracted with dichloromethane (2 x 10 mL).  
The combined organic layers were washed with brine (20 mL) 
and dried over Na2SO4, filtered, and concentrated under reduced 
pressure.  The crude residue was purified by silica gel column 
chromatography (50%  75%   100% ethyl acetate in hexanes) 
to afford tricyclic diol 24 as a colorless oil (36.8 mg, 65% yield). 
4.3.3. Sodium borohydr ide reduct ion of  d io l  24 .   
To a solution of diol 24 (5.7 mg, 0.0194 mmol, 1.0 equiv) in 
1:1 CH2Cl2/MeOH (2.0 mL total volume) was added a solution of 
sodium borohydride (7.3 mg, 0.194 mmol, 10.0 equiv) in 1:1 
CH2Cl2/MeOH (0.5 mL total volume) at –78 °C.  The reaction 
mixture was allowed to warm to 23 °C over the course of six 
hours.  When TLC analysis indicated full consumption of starting 
material, the reaction was quenched with acetone (1.0 mL) and 
2N NaOH (1.0 mL).  The phases were separated, and the organic 
layer was immediately washed with brine (10 mL) and dried over 
sodium sulfate.  After filtration and concentration u der reduced 
pressure, the crude residue was subjected to silica gel column 
chromatography (100% ethyl acetate), but tetra-hydroxylated 
compound 26 was not obtained. 
4.3.4. Tr icyc l ic  monoester  16 .   
To a solution of diol 24 (6.7 mg, 0.0228 mmol, 1.0 equiv) in 
dichloromethane (1.0 mL) at 23 °C were added EDCI (6.5 mg, 
0.0342 mmol, 1.5 equiv), DMAP (2.8 mg, 0.0228 mmol, 1.0
equiv), and butyric acid (3.2 µL, 0.0342 mmol, 1.5 equiv).  The 
resulting mixture was stirred at 23 °C for 24 hours, after which 
time the reaction was diluted with ethyl acetate (5 mL) and 
washed with 0.5 M HCl (3 mL), sat. aq. NaHCO3 (3 mL), and 
brine (3 mL).  The combined organics were dried over Na2SO4, 
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filtered, and concentrated, and the crude residue was purified by 
silica gel column chromatography (15%   25%   35%   55% 
ethyl acetate in hexanes) to afford monoester 16 as a colorless oil 
(4.4 mg, 53% yield).  Rf = 0.33 (25% hexanes in ethyl acetate); 
1H NMR (CDCl3, 500 MHz) δ 4.86 (d, J = 10.6 Hz, 1H), 2.55 (d, 
J = 15.1 Hz, 1H), 2.53–2.46 (m, 1H), 2.41–2.34 (m, 1H), 2.32 (t, 
J = 7.4 Hz, 2H), 2.27–2.17 (m, 2H), 2.14 (d, J = 15.2 Hz, 1H), 
2.07–2.01 (m, 1H), 2.01–1.95 (m, 1H), 1.88 (d, J = 12.6 Hz, 1H), 
1.79–1.73 (m, 1H), 1.70–1.64 (m, 3H), 1.55 (m, 1H), 1.20 (s, 
3H), 1.17 (d, J = 14.3 Hz, 1H), 1.14 (s, 3H), 1.13–1.07 (m, 1H), 
0.94 (t, J = 7.4, 14.8 Hz, 3H), 0.95 (s, 3H); 13C NMR (CDCl3, 
126 MHz) δ 218.0, 211.8, 172.7, 74.6, 73.5, 61.1, 52.6, 50.9, 
47.4, 43.3, 40.2, 40.0, 36.5, 34.3, 31.1, 28.6, 21.8, 20.2, 18.6, 
18.0, 13.8 ; IR (Neat Film, KBr) 3503 (br), 2964, 2934, 2875, 
1735, 1705, 1458, 1379, 1258, 1177, 988, 732 cm-1; HRMS 
(FAB+) m/z calc’d for C21H31O4 [M–OH]
+: 347.2222, found 
347.2229; [α]25D –277.4 (c 1.00, CHCl3).   
4.3.5. Ester i f ica t ion of  24  us ing butyry l  ch lor ide.   
To a solution of diol 24 (30.0 mg, 0.102 mmol, 1.0 equiv) in 
3:1 CH2Cl2/pyridine (4.0 mL total volume) at 23 °C were added 
butyryl chloride (53 µL, 0.510 mmol, 5.0 equiv) and DMAP 
(12.5 mg, 0.102 mmol, 1.0 equiv).  The resulting mixture was 
stirred at 23 °C for 2 hours, after which time the reaction was 
cooled to 0 °C and quenched with H2O (5.0 mL) and saturated 
aq. NH4Cl (5.0 mL), then extracted with ethyl acetate (2 x 10 
mL).  The combined organics were washed with brine, dri d over 
Na2SO4, filtered, and concentrated in vacuo.  The crude residue 
was purified by silica gel column chromatography (15%   30%   
45% ethyl acetate in hexanes) to afford monoester 16 as a 
colorless oil (20.2 mg, 54% yield). 
4.3.6. Ester i f ica t ion of  24  us ing butyr ic anhydr ide.   
To a solution of diol 24 (36.8 mg, 0.125 mmol, 1.0 equiv) in 
dichloromethane (6.5 mL) was added triethylamine (70 µL, 0.500 
mmol, 4.0 equiv), butyric anhydride (60 µL, 0.375 mmol, 3.0 
equiv), and DMAP (7.6 mg, 0.0625 mmol, 0.5 equiv) at 23 °C.  
The resulting mixture was stirred for 1 hour, after which time 
TLC analysis indicated full consumption of 24.  The reaction was 
diluted with dichloromethane (10 mL) and washed with water (2 
x 20 mL).  The organic layer was dried over MgSO4, filtered, and 
concentrated under reduced pressure, and the resulting crude 
residue was purified by silica gel column chromatography (25% 
  40%   60% ethyl acetate in hexanes) to afford monoester 16 as 
a colorless oil (33.3 mg, 73% yield). 
4.3.7. Tr is -hydroxyla ted t r icyc le 25 .   
To a solution of diketone 16 (31.0 mg, 0.0851 mmol, 1.0 
equiv) in dichloromethane (2.0 mL) and methanol (2.0 mL) was 
added a solution of sodium borohydride (32.2 mg, 0.851 mmol, 
10.0 equiv) in dichloromethane (1.0 mL) and methanol (1.0 mL) 
at –78 °C.  The reaction mixture was allowed to warm to 23 °C 
over the course of 6 hours.  When TLC analysis indicated full 
consumption of starting material, the reaction was quenched with 
acetone (2.0 mL) and 2N NaOH (2.0 mL).  The phases were 
separated, and the organic layer was immediately washed with 
brine (10 mL) and dried over sodium sulfate.  After ilt ation and 
concentration under reduced pressure, the crude residue was 
purified by silica gel column chromatography (15% ethyl acetate 
in hexanes), furnishing triol 25 (25.0 mg, 80% yield).  Triol 25:   
Rf = 0.19 (25% hexanes in ethyl acetate); 
1H NMR (CDCl3, 400 
MHz) δ 4.87 (dd, J = 11.1, 2.5 Hz, 1H), 4.01 (td, J = 6.2, 2.9 Hz, 
1H), 3.69 (dd, J = 8.7, 5.8 Hz, 1H), 2.31 (t, J = 7.4 Hz, 2H), 
2.06–1.99 (m, 1H), 1.99–1.95 (m, 1H), 1.94–1.88 (m, 1H), .84–
1.78 (m, 1H), 1.73–1.62 (m, 6H), 1.60 (m, 1H), 1.53–1.50 (m, 
2H), 1.38–1.35 (m, 1H), 1.34–1.32 (m, 1H), 1.26–1.23 (m, 1H), 
1.18 (s, 3H), 1.13 (s, 3H), 1.12 (s, 3H), 0.96 (t, J = 7.4 Hz, 3H); 
13C NMR (CDCl3, 101 MHz) δ 172.8, 80.5, 76.4, 74.2, 73.3, 
57.6, 46.4, 45.9, 45.7, 45.1, 39.3, 37.5, 36.6, 35.0, 33.4, 29.6, 
23.2, 22.5, 21.5, 18.7, 13.9; IR (Neat Film, KBr) 3402 (br), 2933, 
2874, 1715, 1463, 1384, 1307, 1263, 1196, 1097, 1032, 916, 732 
cm–1; HRMS (ESI+) m/z calc’d for C21H36O5K [M+K]
+: 
407.2194, found 407.2196; [α]25D –20.7 (c 1.00, CHCl3).   
4.3.8. Mono-reduct ion product  27 .   
A mono-reduction product, diol 27, was also generated from 
the borohydride reduction of 16 described above and was isolated 
separately from the column (5.6 mg, 18% yield).  Diol 27: Rf = 
0.25 (25% hexanes in ethyl acetate); 1H NMR (CDCl3, 400 MHz) 
δ 4.90 (d, J = 10.7 Hz, 1H), 4.19 (t, J = 5.3, 2.1 Hz, 1H), 2.35–
2.26 (m, 4H), 2.14–2.06 (m, 3H), 1.81–1.76 (m, 2H), 1.75–1.71 
(m, 1H), 1.70–1.65 (m, 3H), 1.63–1.59 (m, 2H), 1.31 (s, 3H), 
1.27–1.24 (m, 2H), 1.22 (s, 3H), 1.18–1.13 (m, 1H), 0.96 (t, J = 
7.1, 14.8 Hz, 3H), 0.95 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ 
214.7, 172.7, 80.5, 74.8, 73.7, 60.5, 53.7, 53.1, 52.5, 43.3, 40.7, 
38.3, 36.9, 36.6, 34.5, 28.8, 23.9, 22.6, 18.6, 18.2, 13.8; IR (Neat 
Film, KBr) 3443 (br), 2964, 2934, 1731, 1694, 1463, 1 84, 1264, 
1190, 1140, 1030, 992, 920, 732 cm–1; HRMS (FAB+) m/z calc’d 
for C21H35O5 [M+H]
+: 367.2484, found 367.2471; [α]25D –21.9 (c 
1.21, CHCl3). 
4.3.9. Cyanth iw ig in–gagunin hybr id  14a .   
To a solution of tricyclic triol 25 (10.2 mg, 0.0277 mmol, 1.0 
equiv) in dichloromethane (2.0 mL) was added triethylamine (30 
µL, 0.222 mmol, 8.0 equiv), butyric anhydride (30 µL, 0.166 
mmol, 6.0 equiv), and DMAP (3.4 mg, 0.0277 mmol, 1.0 equiv) 
at 23 °C.  The resulting mixture was stirred for 2 hours, after 
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which time TLC analysis indicated full consumption of 25.  The 
reaction was diluted with dichloromethane (5 mL) and washed 
with water (2 x 10 mL).  The organic layer was dried over 
MgSO4, filtered, and concentrated under reduced pressure, and 
the resulting crude residue was purified by silica gel column 
chromatography (10%  40%   60% ethyl acetate in hexanes) to 
afford cyanthiwigin–gagunin hybrid 14a as a colorless oil (11.4 
mg, 81% yield).  Rf = 0.16 (20% ethyl acetate in hexanes); 
1H 
NMR (CDCl3, 500 MHz) δ 5.10–5.06 (m, 1H), 4.95–4.89 (m, 
2H), 2.32–2.29 (m, 2H), 2.28–2.23 (m, 4H), 2.01 (ddd, J = 14.9, 
7.4, 3.1 Hz, 1H), 1.94 (dd, J = 13.9, 10.9 Hz, 1H), 1.88–1.82 (m, 
1H), 1.74–1.69 (m, 2H), 1.69–1.61 (m, 8H), 1.59 (d, J = 4.3 Hz, 
1H), 1.56–1.51 (m, 3H), 1.24 (m, 2H), 1.19 (s, 3H), 1.11 (s, 3H), 
1.08 (s, 3H), 1.06–1.01 (m, 1H), 0.99–0.92 (m, 9H); 13C NMR 
(CDCl3, 126 MHz) δ 173.2, 173.2, 172.8, 81.4, 75.7, 74.0, 73.9, 
53.5, 46.8, 45.1, 44.4, 41.9, 40.6, 36.9, 36.8, 36.6, 36.1, 34.6, 
29.5, 29.5, 23.7, 22.8, 19.2, 18.6, 18.6, 18.5, 13.9, 13.8 (x2); IR 
(Neat Film, KBr) 3506 (br), 2966, 2936, 2876, 1731, 1461, 1384, 
1258, 1184, 1144, 1092, 981 cm–1; HRMS (FAB+) m/z calc’d for 
C29H49O7 [M+H]
+: 509.3478, found 509.3464; [α]25D –11.4 (c 
1.14, CHCl3). 
4.3.10. Cyanth iw ig in–gagunin hybr id  14b .   
To a solution of tricyclic triol 25 (5.4 mg, 0.0147 mmol, 1.0 
equiv) in dichloromethane (1.0 mL) was added triethylamine (16 
µL, 0.118 mmol, 8.0 equiv), isovaleric anhydride (17 µL, 0.0879 
mmol, 6.0 equiv), and DMAP (1.8 mg, 0.0147 mmol, 1.0 equiv) 
at 23 °C.  The resulting mixture was stirred for 1 hour, after 
which time TLC analysis indicated full consumption of 25.  The 
reaction was diluted with dichloromethane (5 mL) and washed 
with water (2 x 10 mL).  The organic layer was dried over 
MgSO4, filtered, and concentrated under reduced pressure, and 
the resulting crude residue was purified by silica gel column 
chromatography (10%  30% ethyl acetate in hexanes) to afford 
cyanthiwigin–gagunin 14b as a colorless oil (3.1 mg, 39% yield): 
Rf = 0.70 (50% ethyl acetate in hexanes); 
1H NMR (CDCl3, 500 
MHz) δ 5.11–5.08 (m, 1H), 4.98–4.91 (m, 2H), 2.32 (t, J = 7.4, 
14.8 Hz, 2H), 2.27–2.21 (m, 1H), 2.21 (s, 1H), 2.20–2.16 (m, 
4H), 2.16–2.08 (dddd, J = 12.9, 9.5, 8.1, 6.3 Hz, 2H), 2.05–1.99 
(m, 1H), 1.96 (dd, J = 14.0, 11.0 Hz, 1H), 1.85 (m, 1H), 1.83 (s, 
1H), 1.74–1.71 (m, 1H), 1.71–1.67 (m, 2H), 1.66–1.60 (m, 2H), 
1.57–1.52 (m, 2H), 1.31–1.28 (m, 1H), 1.28–1.23 (m, 2H), 1.21 
(s, 3H), 1.12 (s, 3H), 1.10 (s, 3H), 1.00–0.95 (m, 15H); 13C NMR 
(CDCl3, 126 MHz) δ 172.8, 172.7, 172.7, 81.3, 75.7, 74.0, 73.9, 
53.5, 46.6, 45.1, 44.4, 44.2, 44.0, 42.0, 40.5, 36.6, 36.2, 34.7, 
29.6, 29.5, 25.9, 25.7, 23.8, 22.9, 22.7, 22.7, 22.6, 2.6, 19.3, 
18.7, 13.9; IR (Neat Film, KBr) 3499 (br), 2961, 2874, 1731, 
1466, 1384, 1294, 1257, 1189, 1120, 1095, 990 cm–1; HRMS 
(ESI+) m/z calc’d for C31H51O6 [M–OH]
+: 519.3686, found 
519.3700; [α]25D –13.7 (c 0.31, CHCl3). 
4.3.11. Cyanth iw ig in–gagunin hybr id  14c .   
To a solution of tricyclic triol 25 (7.0 mg, 0.0190 mmol, 1.0 
equiv) in dichloromethane (2.0 mL) was added triethylamine (21 
µL, 0.152 mmol, 8.0 equiv), acetic anhydride (11 µL, 0.114 
mmol, 6.0 equiv), and DMAP (2.3 mg, 0.0190 mmol, 1.0 equiv) 
at 23 °C.  The resulting mixture was stirred for 1 hour, after 
which time TLC analysis indicated full consumption of 25.  The 
reaction was diluted with dichloromethane (5 mL) and washed 
with water (2 x 10 mL).  The organic layer was dried over 
MgSO4, filtered, and concentrated under reduced pressure, and 
the resulting crude residue was purified by silica gel column 
chromatography (20%  40% ethyl acetate in hexanes) to afford 
cyanthiwigin–gagunin 14c as a colorless oil (4.5 mg, 54% yield): 
Rf = 0.56 (40% hexanes in ethyl acetate); 
1H NMR (CDCl3, 500 
MHz) δ 5.08–5.05 (m, 1H), 4.93 (dd, J = 10.9, 1.8 Hz, 1H), 4.89 
(t, J = 4.1 Hz, 1H), 2.31 (t, J = 7.4 Hz, 2H), 2.26–2.17 (m, 1H), 
2.04 (s, 3H), 2.03 (s, 3H), 2.02–1.98 (m, 1H), 1.94 (dd, J = 13.9, 
10.9 Hz, 1H), 1.81 (s, 1H), 1.75–1.70 (m, 2H), 1.69–1.65 (m, 
2H), 1.64–1.60 (m, 1H), 1.59–1.52 (m, 4H), 1.26–1.22 (m, 2H), 
1.20 (s, 3H), 1.12 (s, 3H), 1.09 (s, 3H), 1.05 (ddd, J = 11.9, 9.7, 
1.7 Hz, 1H), 0.97 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 126 
MHz) δ 172.8, 170.7, 170.6, 81.6, 75.7, 74.3, 74.0, 53.4, 46.8, 
45.0, 44.4, 41.8, 40.6, 36.6, 36.1, 34.7, 29.5, 29.5, 23.6, 22.9, 
21.6, 21.5, 19.2, 18.7, 13.9; IR (Neat Film, KBr) 3457 (br), 2966, 
2934, 2877, 1732, 1463, 1384, 1245, 1184, 1145, 1022, 982, 908 
cm–1; HRMS (FAB+) m/z calc’d for C25H41O7 [M+H]
+: 453.2852, 
found 453.2835; [α]25D –12.3 (c 0.42, CHCl3). 
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